secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eledon Pharmaceuticals, Inc. (ELDN)
CIK:        0001404281
Form:       8-K
Filed at:   2024-07-10T23:59:59+00:00
Accession:  0000950170-24-082739
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Eledon Pharmaceuticals completes $2.1M unregistered stock sale of 909,088 shares
--------------------------------------------------------------------------------

- Sold 909,088 shares of common stock in second closing under Securities Purchase Agreement dated April 28, 2023.
- Gross proceeds of approximately $2.1 million from institutional and accredited investors.
- Exempt from registration under Section 4(a)(2) and Rule 506(b).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404281/000095017024082739/0000950170-24-082739-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404281/000095017024082739/eldn-20240708.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-082739

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer